Explore more publications!

Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on March 16, 2026

Hypno Life Radio Show Brings Modern Hypnosis and Mental Wellness to the Public
Arizona Senate to Vote on Resolution Encouraging Daily Physical Activity for Students
Austin Natural Mattress Celebrates 26 Years as Central Texas Leader in Organic and Non-Toxic Sleep Products
Pattern Discovers New microRNA Drug for Treatment of Glioblastoma Cancer
Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance
CMR Surgical Advances Physical AI to Support the Future of Robotic Surgery with NVIDIA
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions